Gemina Laboratories Ltd.
GLABF
$0.05
-$0.02-27.54%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.08M | -2.47M | -2.87M | -2.94M | -2.51M |
| Total Depreciation and Amortization | 45.80K | 65.50K | 83.10K | 82.20K | 80.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 261.00K | 340.80K | 464.60K | 477.60K | 154.10K |
| Change in Net Operating Assets | 1.77M | 1.91M | 1.98M | 1.43M | 1.35M |
| Cash from Operations | 300.00 | -153.60K | -340.00K | -954.90K | -923.60K |
| Capital Expenditure | -- | -- | -- | -- | 12.00K |
| Sale of Property, Plant, and Equipment | 13.00K | 13.00K | 13.00K | 13.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 13.00K | 13.00K | 13.00K | 13.00K | 12.00K |
| Total Debt Issued | 0.00 | 50.00K | 50.00K | 910.00K | 910.00K |
| Total Debt Repaid | -76.90K | -73.10K | -100.10K | -117.40K | -112.60K |
| Issuance of Common Stock | 9.60K | 9.60K | 526.40K | 518.40K | 516.80K |
| Repurchase of Common Stock | -- | -1.60K | -1.60K | -1.60K | -1.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.10K | -14.50K | -14.50K | -27.20K | -33.30K |
| Cash from Financing | -43.40K | -20.40K | 337.30K | 942.60K | 939.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | -30.20K | -161.20K | 10.00K | 500.00 | 27.90K |